Vaccines Market to Grow at 6.7% CAGR and to Reach US$ 50.42 Billion by 2023, Led by Hepatitis and Influenza

PUNE, India, August 22, 2018 /PRNewswire/ --

ReportsnReports added vaccines market report with major players operating are GlaxoSmithKline, plc (UK), Pfizer, Inc. (US), Merck & Co., Inc. (US), Sanofi Pasteur SA (France), Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions, Inc. (US), Johnson & Johnson (US), MedImmune, LLC (US), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo (Japan), Protein Sciences Corporation (US), and Panacea Biotec (India).

Browse 93 Market Data Tables and 46 Figures spread through 184 Pages and In-depth TOC on "Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR, Varicella, Dengue), Route (IM/SC, Oral), Patient (Pediatric, Adult), Type - Global Forecast to 2023" at https://www.reportsnreports.com/reports/267258-vaccine-market-by-techn ... .

The vaccines market is expected to reach USD 50.42 billion by 2023 from USD 36.45 billion in 2018, at a CAGR of 6.7%. Rising prevalence of diseases, increasing government and non-government funding for vaccine development, and increasing company initiatives to enhance R&D are driving the growth of the vaccines market.

Vaccines Market, By Technology 

1 Introduction

2 Conjugate Vaccines

3 Inactivated and Subunit Vaccines

4 Live Attenuated Vaccines

5 Recombinant Vaccines

6 Toxoid Vaccines

Vaccines Market, By Route of Administration 

1 Introduction

2 Intramuscular and Subcutaneous Administrations

3 Oral Administrations

4 Other Routes of Administration

The pneumococcal segment is expected to account for the largest share of the vaccines market in 2018. The large share of this segment can primarily be attributed to increasing government investments in pneumococcal vaccination programs and high incidence of pneumococcal diseases.

Order the "Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR, Varicella, Dengue), Route (IM/SC, Oral), Patient (Pediatric, Adult), Type - Global Forecast to 2023" Report Now at https://www.reportsnreports.com/purchase.aspx?name=267258 .